Pfizer requests location for Zoloft MDL
Pfizer has requested that Zoloft multidistrict litigation, if it is approved, take place in the U.S. District Court for the Southern District of New York, but also suggested the Northern and Southern Districts of Mississippi and the Northern District of Ohio as other possible locations for Zoloft multidistrict litigation.
A multidistrict litigation case would allow one federal judge to handle more than one Zoloft lawsuit, especially if the lawsuits dealt with similar circumstances or side effects. This would help plaintiffs and defendants reach consensuses about settlements and other matters in a more efficient way, as pretrial processes would be combined in similar cases so that litigation could move more quickly through the legal system. Pfizer is arguing that consolidating cases into a multidistrict litigation lawsuit would be beneficial to plaintiffs and defendants alike.

